SSI 2024 Review: Strategic Refinements, Key Investment Updates, and Performance Insights

317 Views06 Jan 2025 16:11

SSI's 2024 Tracking Portfolio saw a 1% loss, prompting a refined categorization of investment ideas for 2025. Kronos Bio terminated its Genentech partnership...

What is covered in the Full Insight:

Introduction and Thanks
Performance Review for 2024
Investment Idea Updates
Portfolio and Pitch Strategy Refinement
Conclusion and Full Write-ups

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 5-minute read)

Discussions

(Paid Plans Only)

Top Quartile

Special Situation Investments

Event-Driven Investment Opportunities

EquitiesEvent-Driven

View Full Profile

Price Chart(Sign Up to Access)

Insight Stream